| Message | Subject | Recs | Date/Time (ET) |
| Dyax (DYAX) off about 30% as earnings disappoint.
I don't know enough about t | biotech firesales | | 04/26/2013 10:24:12 AM |
| Nature blurb on studies of complete response outliers in failed oncology trials: | Personalized Medicine: Molecular Dx | | 04/23/2013 01:23:32 PM |
| Rigel (RIGL) off 33% on P3 efficacy failure in RA. There are a couple of more s | biotech firesales | | 04/05/2013 10:10:21 AM |
| PolyMedix (PYMXD), having just done a reverse split, files for chapter 7, splutt | biotech firesales | | 04/01/2013 03:34:37 PM |
| Unless we're seeing a bad April Fool's joke, PYMX has filed for chapter 7. A li | PolyMedix | | 04/01/2013 03:32:57 PM |
| >>NPS regains right to drugs from Takeda for $50 mln in NPS shares
| NPSP NPS Pharmaceutical | | 03/19/2013 01:55:39 PM |
| Spectrum (SPPI) off 36% on drastically -- ~40% -- reduced revenue guidance.
C | biotech firesales | | 03/13/2013 10:30:13 AM |
| >>Cytolytic nanoparticles attenuate HIV-1 infectivity Joshua | Indications -- HIV | | 03/10/2013 02:16:45 PM |
| Why not start a company specific board and post what you've got there? | biotech fireworks | 1 | 03/08/2013 03:50:11 PM |
| "everybody sick of the sober me, yet?"
I was debating asking which vice it wa | momo-T/FIF | | 03/01/2013 07:01:43 PM |
| Having gotten Hematide approved, Affymax is now facing having to pull it off the | Amgen Inc. (AMGN) | | 02/25/2013 03:32:12 PM |
| Affymax (AFFY), which got its drug approved has been forced to do a recall due t | biotech firesales | | 02/25/2013 03:29:26 PM |
| "why you should always read past the title and the abstract."
[url=http://]h | Biotech Valuation | | 02/22/2013 11:24:38 AM |
| (OT) re renewables integrating with conventional power. One of the problems for | Biotech Valuation | | 02/15/2013 04:00:36 PM |
| Amicus (FOLD) off ~26% after presenting additional data from this trial, along w | biotech firesales | | 02/15/2013 03:42:02 PM |
| Discovery Labs (DSCO) up 22% on a better than usual financing deal. C | biotech fireworks | | 02/14/2013 03:19:35 PM |
| >>[b]13-Feb-2013[/b]
[b]Entry into a Material Definitive Agreement, Creation | dsco Discovery Laboratories | | 02/14/2013 03:17:05 PM |
| Peregrine (PPHM) off 20% or so on P2 failure in pancreatic cancer (Bavi + Gemzar | biotech firesales | | 02/13/2013 04:00:57 PM |
| "Genomic responses in mouse models poorly mimic human inflammatory dis | Indications -- Psoriasis/Chronic Inflamm | | 02/13/2013 11:47:54 AM |
| I see it had the desired effect, good job.
I don't follow the company as much | Array Pharmaceuticals ARRY | | 02/04/2013 12:05:34 PM |
| But hearing this doesn't quite gybe with the slides shown during the quarterly p | Array Pharmaceuticals ARRY | | 02/03/2013 06:21:06 PM |
| "AstraZeneca has ended nine drug development programs since June 30, including s | Array Pharmaceuticals ARRY | | 02/03/2013 01:52:26 PM |
| >>Daiichi Sankyo Company, Limited (TSE 4568) and ArQule, Inc. (ARQL) today anno | ArQule, Inc. (ARQL) | | 01/31/2013 08:32:07 PM |
| Ha! I swear I looked at that more than once. Well, it's time for my eye doctor | Biotech Valuation | | 01/30/2013 08:14:55 PM |
| Ah, no. It is clear from the inclusion criteria you dug up that Valea | Biotech Valuation | | 01/30/2013 12:28:39 PM |
| I don't know if age really affects cure rate. But I do know that including pati | Biotech Valuation | | 01/30/2013 01:57:05 AM |
| Down because results not looking quite as good as Valeant's efinaconaz | biotech firesales | | 01/29/2013 01:14:14 PM |
| Gattex approved, no CC until 1/2/2013, though. Wacky day, approval ex | NPSP NPS Pharmaceutical | | 12/21/2012 02:08:14 PM |
| Amicus (FOLD) off 45% after lead drug whiffs against Fabry's Disease in P3. Don | biotech firesales | | 12/20/2012 11:13:06 AM |
| Seeing Alexion's asfotase alfa for hypophosphatasia mentioned as a possibility ( | momo-T/FIF | | 12/14/2012 02:34:17 PM |
| Indeed, I'm saying it's complicated, and we peons didn't have any hints I'm awar | Biotech Valuation | | 12/14/2012 02:27:04 AM |
| Are the folks at Purdue kicking themselves?
Cheers, Tuck
| Infinity Pharmaceuticals | | 12/13/2012 08:36:53 PM |
| That is SO 2008. Same group now suggests beta isoform does, too.
[url=http:/ | Biotech Valuation | | 12/13/2012 08:25:09 PM |
| I'm puzzled, too, but the dual inhibition by IPI-145 of the delta and gamma isof | Exelixis, Inc. (EXEL) | | 12/13/2012 07:58:43 PM |
| Good to see some discussion of this by folks with a stronger science background | Biotech Valuation | | 12/13/2012 04:15:05 PM |
| And she's outta there. Haven't heard who's on deck.
Cheers, Tuck
| The Securities and Exchange Commission | | 11/27/2012 04:52:44 PM |
| CAFC denies petition for en banc hearing, so it's off to US Supreme Court for th | Momenta Pharmaceuticals Inc. | | 11/20/2012 04:03:56 PM |
| I'm going to guess ALNY is up slightly and TKMR fireworks. Although, looking at | Biotech Valuation | | 11/13/2012 12:52:38 AM |
| I bought in three slugs; managed to come within 50 cents of the bottom on the th | Xenoport | | 11/09/2012 04:40:04 PM |
| Xenoport gets Horizant back:
[url=http:///]http://us.gsk.com/html/media-news/ | Xenoport | | 11/08/2012 01:49:34 PM |
| Myriad Genetics (MYGN), strong all day, and now up 16% on earnings bea | biotech fireworks | | 11/06/2012 03:40:59 PM |
| PR upfront states that insiders may be selling some stock when the window opens | biotech firesales | | 11/05/2012 03:08:46 PM |
| Optimer (OPTR) off 17% after hours after reporting earnings. This could be a fa | biotech firesales | | 11/01/2012 04:16:25 PM |
| Pain Therapeutics & DuRect (DRRX) both off ~33% after Pfizer, on its earnings c | biotech firesales | | 11/01/2012 01:16:19 PM |
| Immunogen (IMGN), which has run up lately as possible FDA approval of | biotech firesales | | 10/26/2012 03:26:34 PM |
| Royalty structure for T-DM1 not as favorable to Immunogen as market thought:
| ImmunoGen | | 10/26/2012 01:41:00 PM |
| Novartis sales of mEnox this q = $34 million, while Watson reports much higher t | Momenta Pharmaceuticals Inc. | | 10/25/2012 12:37:53 PM |
| Karst updates as rehearing petitions have been filed:
[url=http:///]http://ww | Momenta Pharmaceuticals Inc. | | 10/24/2012 06:01:53 PM |
| So Aegerion's drug and Isis' kynamro both given a thumbs up by the AC, with a RE | Isis Pharmaceuticals (ISIP) | | 10/18/2012 04:17:54 PM |
| Depends on the cancer. Three different types were referenced in the briefing do | biotech firesales | | 10/17/2012 01:46:46 AM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
